ID: ALA2381020

Max Phase: Preclinical

Molecular Formula: C20H25ClN2O3

Molecular Weight: 376.88

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](C1CCCCC1)N1C(=O)CC(=O)N(CCc2cccc(Cl)c2)C1=O

Standard InChI:  InChI=1S/C20H25ClN2O3/c1-14(16-7-3-2-4-8-16)23-19(25)13-18(24)22(20(23)26)11-10-15-6-5-9-17(21)12-15/h5-6,9,12,14,16H,2-4,7-8,10-11,13H2,1H3/t14-/m1/s1

Standard InChI Key:  YDLHMUFCKVDRIE-CQSZACIVSA-N

Associated Targets(non-human)

CACNA1C Voltage-gated L-type calcium channel alpha-1C subunit (335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1d Voltage-gated L-type calcium channel alpha-1D subunit (336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 376.88Molecular Weight (Monoisotopic): 376.1554AlogP: 4.03#Rotatable Bonds: 5
Polar Surface Area: 57.69Molecular Species: ACIDHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.00CX Basic pKa: CX LogP: 4.32CX LogD: 1.99
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.73Np Likeness Score: -0.96

References

1. Kang S, Cooper G, Dunne SF, Luan CH, Surmeier DJ, Silverman RB..  (2013)  Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.,  56  (11): [PMID:23651412] [10.1021/jm4005048]

Source